Le renouveau des antagonistes de l'atdostérone [The revived interest in aldosterone antagonists]


Autoria(s): Waeber B.
Data(s)

2006

Resumo

Aldosterone plays a pivotal role in sodium and water homeostasis, in particular in patients with heart failure or high blood pressure. These medications, when used on top of a standard therapy, improve the outcome of patients with heart failure and are also effective in lowering blood pressure of hypertensive patients. The major risk associated with the use of these antagonists is hyperkalemia, which can be prevented in avoiding their prescription in patients with impaired renal function. Eplerenone has the advantage, compared with spironolactone, to be better tolerated in terms of "hormonal" adverse effects.

Identificador

http://serval.unil.ch/?id=serval:BIB_F2AC51DDF1E7

isbn:1660-9379

pmid:17019841

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 2, no. 78, pp. 2055-2058

Palavras-Chave #Aldosterone Antagonists; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Hypokalemia; Spironolactone; Treatment Outcome
Tipo

info:eu-repo/semantics/review

article